IDEX (IEX) Q4 2004 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2004 earnings summary
9 Nov, 2026Executive summary
Engineered industrial products portfolio spans pumps and fluid-handling equipment, dispensing systems, firefighting and rescue products, and stainless steel banding and clamping devices; operations serve diverse global end markets.
Three business groups generated distinct shares of 2004 sales and operating income, with international sales representing 38% of Pump Products, 63% of Dispensing Equipment, and 45% of Other Engineered Products.
Financial highlights
Pump Products accounted for 58% of 2004 sales and 54% of operating income; Dispensing Equipment contributed 18% and 19%, respectively; Other Engineered Products contributed 24% and 27%.
Segment performance
Pump Products Group offers pumps, compressors, flow meters, injectors, valves, and controls; its 2004 portfolio served industrial, water treatment, medical, petroleum, food, biotech, and drug-processing markets.
Dispensing Equipment Group provides colorant and paint dispensing, mixing and metering equipment, refinishing systems, and centralized lubrication products; 63% of group sales were outside the U.S. in 2004.
Other Engineered Products Group supplies fire and rescue equipment and stainless steel banding and clamping products; 45% of group sales were outside the U.S. in 2004.
Latest events from IDEX
- Margin gains and record cash generation offset weak base-business demand.IEX
Q4 2002 - Pump Products led FY2003 results as diversified industrial operations managed short backlogs and legal uncertainty.IEX
Q4 2003 - Organic growth accelerated to 10%, while international and acquisition risks remain material.IEX
Q4 2005 - Organic growth, acquisitions and Lean gains lifted sales and margins in 2006.IEX
Q4 2006 - Organic growth and higher gross margin lifted FY07 earnings as acquisition activity expanded the portfolio.IEX
Q4 2007 - Acquisitions lifted sales 10%, but impairment, restructuring and weak dispensing demand cut earnings.IEX
Q4 2008 - Broad organic weakness cut FY09 sales 11%, while cash flow funded operations and investment.IEX
Q4 2009 - FY10 recovery lifted sales 14% and operating margin to 16.5%; FY11 EPS guided to $2.23–$2.33.IEX
Q4 2010 - FY11 sales climbed 22%; FY12 diluted EPS guidance was $2.74–$2.82.IEX
Q4 2011